Delivering API-In-Capsule For Potent, Low-Flow Compounds

Manufacturing first-in-human (FIH) supplies can become particularly challenging when active pharmaceutical ingredients (APIs) exhibit poor flow characteristics and require potent handling controls. As clinical programs advance and demand shifts from small initial batches to larger re-supply quantities, manual capsule filling can quickly become impractical, creating bottlenecks in both timelines and resource utilization.

This case study demonstrates how an automated API-in-capsule strategy successfully addressed these challenges for a low-flow, potent compound. By optimizing processing parameters and leveraging specialized containment solutions, large-scale capsule production was completed efficiently while maintaining operator protection and minimizing process disruptions. The approach reduced the labor-intensive burden associated with manual filling and enabled rapid scale-up from early clinical supplies to significantly higher-volume requirements.

For development teams seeking faster, safer, and more efficient pathways to clinical supply manufacturing, this example highlights how the right technology and process design can help overcome common formulation and operational hurdles.